Nano-enabled medical products began emerging on the market over a decade ago, and some have evolved as the best-sellers in their therapeutic categories. The leading areas in which nanomedical products have made an impact are CNS diseases, cancer, cardiovascular disease, and infection control.
Moreover, the availability of technologically advanced products and significant investments in nanotechnology-based research in drug discovery studies and cancer therapeutics will also drive the North American market during the forecast period. The Asia-Pacific region's high growth rate will be due to the drive to address unmet healthcare needs, high prevalence of cancer, high investments in nanotechnology-based research, and growing R&D funding for cancer drug discovery and personalized medicine opportunities.
The report examines the current and forecast market potential for nanomedicine. It offers a detailed analysis of the market background, technological advancements, competitive environment, drivers and restraints, and market growth trends.
The report includes market projections through 2026, detailing the market share for nanomedicine based on therapeutic areas and geography. By therapeutic area, the nanomedicine market is segmented into anticancer, CNS products, anti-infectives, anti-inflammatories, cardiovascular, and others. By geography, the nanomedicine market has been segmented into Europe, North America, Asia-Pacific (APAC), and the Rest of the Word (ROW).
The Report Includes
An overview of the global markets for nanotechnology used in medical applications
Estimation of the market size, and analyses of the global market trends with data from 2019, 2020, 2021, with projection of CAGR through 2026
A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications
Information on significant products in which the nano dimension has made a significant contribution to product effectiveness
A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine
Identification of key market dynamics, trends, opportunities, and factors influencing the global market and highlights of the market potential for nanotechnology used in medical applications based on type, application, and region
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Company profiles of major players in the market, including Abbott, Abraxis Bioscience, Elan, Orthovita Inc., EyePoint Pharmaceuticals Inc. and Farfield Scientific Ltd
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Applications
Drug Delivery
Drugs and Therapy
in Vivo Imaging
in Vitro Diagnostics
Biomaterials
Active Implants
Overview
Medical Nanotechnology: Nanomedicine
Nanotechnology
Nanotechnology Uses
Medical Applications
Environmental Applications
Military Applications
Cosmetics
Nanotechnology Tools
Risks of Nanotechnology
Nanotechnology in the Marketplace
Development of Nanomedical Technologies
Liposomes
Dendrimers
Nanocrystals
Micelles
Fullerenes
Polymeric Nanoparticles
Nanoparticle-Drug Conjugates
Ligand-Targeted Nanoparticles
Ceramic Nanoparticles
Virosome Nanoparticles
Therapeutic Uses of Nanomedicine
Cancer Diagnostics and Therapy
Drug Delivery
Future Trends and Research Possibilities
Non-Invasive Nanodevices
Extracellular Devices
Intracellular Devices
Nanomachines to Control Tissue Healing
Eliminating Viruses
Correcting Chemistry
New Organs and Limbs
Fundamental Nanotechnology Research
Chapter 4 Impact of Covid-19 Pandemic
Chapter 5 Markets for Nanomedicine
Market Drivers
Market Estimates and Forecasts
Global Nanomedicine Market
Main Product Categories
Market Analysis by Clinical Application
Chapter 6 Global Nanomedicine Market Breakdown by Region
About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
US Medical Innovations, LLC (USMI) announced today it has received FDA 510k Clearance (K240297) for the Canady Helios Cold Plasmatm (CHCP) Ablation System for the ablation of soft tissue during surgery. The CHCP system consists of the Canady Helios...
Bioenergy Devco, a global leader in the design, engineering, construction, financing, and operation of advanced anaerobic digester systems, has been named as a winner of the 2024 SEAL Business Sustainability Awards, honoring their leadership,...
DRI Healthcare Trust ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 7, 2024. All of the nominees for election as trustees of the Trust referred to in its management...
In less than four weeks, independent presidential candidate Robert F. Kennedy Jr. will take the stage in Austin, TX, at Consensus 2024, the world's largest, longest-running, and most influential gathering that brings together all sides of the crypto...
Tachyum® today announced that it has added a watchdog timer to its Prodigy® FPGA emulation system to help detect and recovery from device or system malfunction. The mechanism facilitates automatic correction of temporary hardware faults and prevents...
Modern Vision Centers (MVC), a revolutionary network of premier optometry, medical ophthalmology, and refractive surgery practices, proudly announces its official debut, offering comprehensive and personalized eye care solutions that set a new...